CCL18 and malignant colon neoplasm: Elevated CCL18 expression in colon cancer patients was significantly associated with both poorer RFS (n = 1336; HR = 1.33 [1.07–1.65]; p = 0.0099) and reduced OS (n = 1061; HR = 1.34 [1.09–1.65]; p = 0.0048) (Figures S3A and S3B).